Neogen Chemicals Limited — PPTs, 26-07-2026: Investor Presentation

Here's a concise, retail-friendly summary of Neogen Chemicals' Q1 FY27 earnings presentation:

**1. Business Performance:** Neogen Chemicals reported solid Q1 FY27. Consolidated revenue jumped 34% YoY to ₹250.3 Cr, fueled by strong Organolithium sales and higher volumes. Exports made up 30%. Neogen Ionics saw stellar growth, hitting ₹19 Cr revenue (vs ₹5 Cr last year).

**2. Growth Drivers or Strategy:** The company is aggressively expanding its battery materials segment, aiming for leadership in the EV and energy storage space. A strategic CAPEX roadmap also targets growing Organic and Inorganic Chemical capacities.

**3. Recent Developments:** Dahej plant reconstruction is complete, with trial runs started and commercial production imminent. Board approved raising ₹600 Cr via QIP. Battery materials projects are on schedule, with electrolytes trials active and lithium electrolyte salts securing provisional international approvals.

**4. Key Financial Metrics:** Consolidated EBITDA soared 53% to ₹48.2 Cr, and Profit After Tax (PAT) surged 67% to ₹17.1 Cr. EPS grew 62% to ₹6.29.

**5. Management Commentary / Outlook:** Management hailed Q1's robust performance despite headwinds. They see FY27 as a pivotal year for scaling battery materials, with core business growth expected to normalize as the rebuilt Dahej plant becomes fully operational.